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The morphologic analysis of 100 early squamous cell carcinomas of the esophagus has shown that
the barely visible or invisible forms (erythroplakias and occult forms) are predominant. This explains
the pooryieldofupper gastrointestinal (GI) endoscopies in detecting early cancers, at least in Western
countries. Leucoerythroplakias correspond to the most advanced form of early cancers (submucosal
invasion in approximately 38% of cases). Pure erythroplakias and occult forms correspond to in situ
or intramucosal cancers in over 90% of the cases.
Accurate endoscopic staging is possible using morphologic criteria, superficial spread, and rigid-
ity of the wall as parameters. In a prospective study, we show that the degree ofaccuracy of this stag-
ing system reaches 95% for an experienced endoscopist.
TaN0 cancers can benefitfrom an endoscopic treatment (mucosectomy orphotodynamic therapy),
because the risk of lymph node metastasis is low (6%). In TbN0 cancers, the best treatment option
is an esophageal resection with extensive mediastinal lymph node dissection for good surgical can-
didates; PDT combined with adjuvant radiotherapy is a reasonable option for inoperable patients.
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INTRODUCTION
Compared with that in China, Iran, and other Eastern coun-
tries, the incidence ofesophageal carcinoma is much lower
in Europe (< 10/100,000) (Siewert et al., 1977). A system-
atic screening with sponge or balloon cytology is therefore
unadvisable. The only exception to this rule applies to pa-
tients with head and neck cancer, up to 97% ofwhom con-
sumed tobacco and alcohol. For other groups of patients,
endoscopy remains practically the only chance to diagnose
an early asymptomatic esophageal carcinoma. This endo-
scopic screening should be integrated in the routine daily
work of gastroenterologists and head and neck surgeons.
This is why endoscopists should be well aware of the dif-
ferent morphologic patterns of early squamous cell carci-
nomas of the esophagus (Monnier et al., 1981).
MATERIAL AND METHODS
Our experience has been gathered from a systematic en-
doscopic and histopathologic study of 100 early squamous
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cell carcinomas of the esophagus over a 15-year period
(1977-1992). Most of these lesions were diagnosed in pa-
tients during endoscopy before or after treatment for head
and neck cancer, 48 being synchronous and 34 metachro-
nous early second primaries. In only 13 cases did the en-
doscopist detect the early cancer as an isolated lesion.
Technical Details of the Endoscopic Examination
Inheadandneckcancerpatients, the notion ofcommon risk
factors (tobacco and alcohol consumption) is coupled with
the tendency to develop multifocal lesions. This implies the
need not only for endoscopy of the esophagus, but for that
of the mouth, pharynx, and tracheobronchial tree.
The basic requirements of this pretherapy endoscopic
screening are:
1. high expertise of the endoscopist;
2. exploration of the whole mucosal surface exposed to
carcinogens,withspecial attentiontohigh-riskregions;
3. high quality optical instruments (Hopkins system)
and efficient methods of histologic sampling; and
4. capability of detecting early lesions in their infra-
macroscopic stage (epithelial dysplasia, carcinoma
in situ, and microinvasive carcinoma) with the use
of vital staining, for example.
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This oncologically oriented endoscopy calls for a var-
ious number of special instruments that provide optimal
exploration at all levels of the upper aerodigestive tract.
Practically speaking, the patient arrives on an out-patient
basis in the morning, fasts, and leaves the clinic in the
early afternoon. Examination of the oral cavity and phar-
ynx is carried out using a surgical microscope before and
after Toluidine blue gargle. This vital staining procedure,
accomplished in less than five minutes, is done in three
steps. (1) washing or multiple swabbing with 1% acetic
acid (mycolysis); (2) 1-minute washing or swabbing with
1% Toluidine blue (staining); and (3), thorough rinsing
with 1% acetic acid (decolorization).
This method aids in directing biopsy sites and in de-
termining the exact extent of a suspicious cancerous le-
sion. It also facilitates screening of early second primary
cancers devoid of macroscopic signs (epithelial dyspla-
sia, carcinoma in situ). The limits of the method must,
however, be taken into consideration (several false-posi-
tives and one false-negative) (Table 1).
For the pharyngolarynx, the surgical microscope and
laryngeal mirror or the Hopkins 90 angle optics (Von
Stuckrad indirect laryngoscope) are ofconsiderable help,
because they provide a detailed dynamic examination of
the high-risk zones with the use of vital staining.
The patient then undergoes general anesthesia.
Bronchoscopy is performed first, using both a rigid bron-
choscope and a fiberscope. Because the two instruments
are complementary, it is possible to perform an optimal
quality tracheobronchoscopic examination that offers out-
standing optical quality and instrumentation, possibilities
Table 1 False positive and negative reactions to Toluidine blue staining
Reaction Explanation
FALSE POSITIVE
erosions Artifactual penetration
Mucosa fissures of dye into the mucosa
ulcerations
Chronic inflammation
Benign tumors
Ciliated pseudostratified
epithelium
FALSE NEGATIVE
Increased cellularity
Increased number of nuclei
Frequent erosion
Mechanical retention of dye
Goblet cells (mucus)
Affinity of Toluidine blue
for mucopolysaccharides
Severe dysplasia
with parakeratosis
Keratosis prevents the
penetration of dye into
the epithelium
Submucosal extension Lack of submucosal
of tumor penetration of dye
Note.mWith practice, the numberoffalse negatives can be reduced. The
esophagus is ideal for vital staining, especially in the presence of early
lesions, which turn royal blue in most cases.
for examining the larger bronchi using the rigid broncho-
scope, peripheral examination, and biopsy of lesions lo-
cated distal to the segmentarybronchi using the fiberscope.
If a suspicious lesion is detected in the pharyngolaryn-
geal region, direct examination is performed with a sur-
gical microscope and a Toluidine blue test. However, the
anatomic configuration of this region with its folds and
recesses increases the risk of staining artifacts.
Finally, hypopharyngoesophagoscopy is performed
using a rigid esophagoscope equipped with Hopkins op-
tics; Toluidine blue is applied systematically to every sus-
picious lesion. The rigid instrument seems essential for
this exploration, because it provides optimal spreading of
the mucosa in the recesses of the pharyngolaryngeal re-
gion where saliva tends to stagnate, constituting high-risk
cancer zones as well as ofthe sphicter regions. To be com-
pletely reliable, the Toluidine blue staining procedure
(similar to that performed in the oral cavity) must be done
in three steps. Owing to the superior instrumentation pos-
sibilities using the rigid endoscope, staining is carried out
under optimal conditions, whereas with the gastrofiber-
scope, the technical difficulties introduce serious prob-
lems in the interpretation of a possible lesion such as the
impossibility of achieving mechanical decoloration using
a cotton swab soaked in acetic acid. If one wishes to use
a gastrofiberscope, the Lugol iodine solution is preferable,
because it is easier to use. The Lugol iodine solution is a
negative tumor marker that does not stain epithelial dys-
plasias and carcinomas in situ, because these precancer-
ous lesions are devoid of the glycogen present in normal
squamous cell epithelium (Mori et al., 1993).
It goes without saying that this type of "heavy" en-
doscopy (performed, however, on an out-patient basis) is
directed toward high-risk patients who have, or are sus-
pected of having, aerodigestive tract cancer. At the same
time, in Europe it represents our main means of diagno-
sis of curable esophageal cancer.
Endoscopic Morphology
Any classification of the endoscopic morphology ofearly
esophageal carcinoma must include the description of the
fundamental lesions as well as of their mapping (Table 2).
Most often, the fundamental lesions are characterized
by both a color change (leucoplakia or erythroplakia) and
a surface alteration (elevated or depressed). There exists,
moreover, a relationship between these two morphologic
characteristics: an elevated lesion is generally associated
with a leucoplakia, whereas a depressed lesion usually
shows up as areddish lesion atendoscopy (erythroplakia).
However, an esophageal carcinoma in situ can be fiat (no
surface alteration) and show no colorchange; this is calledENDOSCOPIC FINDINGS OF 100 EARLY STAGE ESOPHAGEAL CANCERS 85
Table 2 Fundamental lesions and mapping of early esophageal car-
cinomas
white
red
/
color change
mixed(red+white)
Fundamental no change
lesion elevated
surface irregularity flat
depressed
single lesion
Mapping
multicentric lesion
Note.raThe combination of the fundamental lesions and of their map-
ping results in the classification of four main types of early esophageal
carcinomas.
the "invisible" form (or "occult" according to the Chinese)
of early esophageal cancer.
After the combined study of the morphologic aspects of
thefundamental lesionsand theirmapping,we classify early
esophagealcarcinomas intofourtypes (Siewert etaL, 1977).
Figure la, b Plakelike form of early esophageal cancer with hardly
any surface alteration, a) Although this invasive form of early cancer
hardly shows any surface discoloration, the plakelike rigidity of the
mucosa is suspicious for a submucosal infiltration, b) After Toluidine
blue staining, the lesion is somewhat better visualized, but the uptake of
the dye is only partial.
Leucoplakia
The distinctive morphologic element is the localized and
elevated surface alteration, associated with a whitish dis-
coloration. Usually, the lesion is unique and quite distinct
from the surrounding normal mucosa. Toluidineblue stain-
ing is ofminimal help in this type, because the surface ker-
atosis keeps the dye from penetrating into the mucosa. The
superficial extension generally is moderate, and multi-
centricity is absent or minimal. On the other hand, intra-
luminal growth and deep infiltration of the organ wall are
common, especially ifthis plakelike lesion originates from
severe dysplasia of the basal layers of the epithelium with
early infiltration of the basal cell membrane and with an
intact superficial layer of the epithelium. For this reason,
endoscopic distinction between a carcinoma in situ and a
cancer that has already infiltrated the submucosa is not
easy. The slightest rigidity of the wall is a sign of submu-
cosal invasion. (Fig. 1).
Erythroplakia
This is the most common type, although often it is barely
visible. The dominant feature of this lesion is the reddish
discoloration, which is in general diffuse and slightly de-
pressed compared with the surrounding normal mucosa.
Given the multicentricity and diffuse nature of the lesion,
it is impossible to determine the exact extent of the lesion
without the use of vital staining. In these cases, use of
Toluidine blue as a tumor marker is of particular help in
determining the precise limits of the tumor, which often
is multicentric, and for directing biopsy. These lesions are
Figure lc Histologic sectionshowing asubmucosal extension, whereas
the superficial layers of the epithelium still remain intact. This type of
lesion is derived from a severe dysplasia of the basal layers of the
squamous cell epithelium. Invasion ofthe lamina propria and submucosa
may occur before any significant surface alteration is visible. This
probably corresponds to a most aggressive type of early carcinoma.86 P. MONNIER et al.
characterized by their superficial spread, which is often
extensive (several cm2), whereas intraluminal and intra-
parietal growth appear only later.
It is important to note that a perfectly fiat erythroplakia
can correspond to multiple microinvasive cancer foci. The
multicentricity of the lesion exists not only at the stages
of dysplasia and carcinoma in situ but also in the invasive
stage (Fig. 2).
Leucoerythroplakia
This is the mixed type, composed of white, localized, el-
evated lesions, which are quite distinct and diffuse dis-
seminated erythroplastic lesions. After Toluidine blue
staining, the elevated easily visualized whitish lesions
color very slightly, whereas the poorly visualized reddish
lesions turn royal blue. The leucoerythroplakia tends to
correspond to the most advanced form of early squamous
cell carcinoma in the esophagus, especially if the super-
ficial extension is greater than 2 cm2 (Fig. 3).
MILD AND MODERATE DYSPLASIA
SEVERE DYSPLASIA
CARCINOMA IN SITU
MICROINVASIVE AND IN SITU CARCINOMA
ULCER (BIOPSIES)
Figure 2d Histologic mapping of the lesion. In spite of a very large
superficial extension (several square centimeters and circumferential),
the lesion did not invade beyond the muscularis mucosae, showing that
an extensive but flat and nongranular erythroplakia may still correspond
to a very early lesion.
Occult Form
This is the "invisible" form of dysplasia and carcinoma in
situ. In our series, it never corresponded to an invasive
early carcinoma. This occultform is detected only by vital
staining techniques (Toluidine blue, Lugol Iodine solu-
tion). It probably corresponds to a forerunner of the other
types, mainly the erythroplakia. Often these lesions are
multicentric right from the start (Fig. 4).
Figure 2a, b Microinvasive carcinoma of the esophagus showing as
a circular erythroplakia over several square centimeters, a) The
endoscopic aspect without vital staining is difficult to differentiate from
a Barrett’ esophagus, forexample, b) After vital staining with Toluidine
blue, the lesion shows as multicentric foci of royal blue areas
intermingled with normal unstained mucosa.
Figure 2c On the resected specimen colored with Toluidine blue, the
lesion extends circumferentially over several centimeters in length.
Figure3a Resected specimen ofa leuco-erythroplastic lesion showing
as microinvasive carcinoma at histology analysis, a) The lesion shows as
multicentric foci oferythroplakia, intermingled with white, elevated, and
well-circumscribed leucoplakias.ENDOSCOPIC FINDINGS OF 100 EARLY STAGE ESOPHAGEAL CANCERS 87
Figure 4a, b Occult form of early esophageal carcinoma, a) Before
vital staining with Toluidine blue, this carcinoma in situ of the
posterolateral wall of the esophagus is invisible at endoscopy, b) The
Toluidine blue stain reveals the multicentric aspect of the lesion. The
delineation is precise with a longitudinal extension of 5 cm over one
third of the circumference of the esophagus.
Figure 3b After Toluidine blue staining, leucoplakias stain very little,
whereas erythroplakias turn a royal blue. The precise delineation of
lesions is evident after Toluidine blue.
Histology Method
Given the approximately 80% rate of multicentric tumors
and the fact that it is impossible to microscopically de-
termine the zones of maximal invasion, a histopathologic
examination of step sections of the surgical specimen is
necessary in all cases of early cancer.
The specimen is colored using 1% Toluidine blue so-
lution immediately after surgical removal in the operating
room. The stain shows less affinity for poorly vascular-
ized tissue, and too long a delay between the time ofspec-
imen excisionand vital staining can result in false-negative
results.
Figure 3c Serial histologic sections are necessary to establish a precise
histologic mapping. Here, multiple foci of dysplasias and carcinoma in
situ are evident with a single spot of intramucosal invasion.
Figure 4e The mapping of the resected specimen shows multiple foci
of dysplasias of all grades and ofcarcinoma in situ. Despite a superficial
spread of several square centimeters, this occult lesions shows no sign of
microinvasion on serial histologic sections (around 80 histological slides).
The specimen is then pinned to a cork board and pho-
tographed to life size (format 1/1). After formalin fixation,
all lesions are examined histologically by step sections
(each 2 mm). The anatomic site ofthe sample immediately
is labelled on a life-size photograph and is precisely ori-
entedby coloring its proximal end with India ink. This pro-
vides precise evaluation ofthe histologic slide and an exact
reconstitution of the mapping of the tumor (Fig. 5).
Another method of anatomopathologic examination
was proposed by Mandard et al., in 1980 (Mandard et al.,
1980). It consists of painting all macroscopically visible
lesions as well as those discovered by vital staining with
green China ink; this makes all the pathologic zones im-
mediately obvious on the histologic slides.
Staging of Early Esophageal Cancers
The choice of an optimal treatment modality depends on
an exact endoscopic staging of the lesion. Beside endo-88 P. MONNIER et al.
Morphological Aspects
Figure 5 Method of histologic examination of surgical specimens. 1)
Vital staining with Toluidine blue in the operating room, immediately
after removal. 2) Optimal spreading ofthe specimen on a cork board and
fixation in formalin. 3) Polaroid photograph 1/1 for precise annotation
of the histologic sampling 4) Step sections (an average of 5 cm2) of all
microscopically visible lesions and those revealed by Toluidine blue
staining. 5) Orientationofeachsampleby coloring theproximal extremity
with black China ink.
scopic ultrasonography, three main criteria help differen-
tiate in situ, microinvasive, and submucosal carcinomas.
These are the endoscopic aspect of the lesion, its superfi-
cial extension, and the presence or absence of a slight lo-
calized rigidity of the esophageal wall. In a prospective
study of 64 cases, we checked the reliability of our endo-
scopic criteria in predicting the in-depth invasion of early
squamous cell carcinomas of the aerodigestive tract
(Monnier et al., 1991). On the basis of these criteria, the
endoscopist establishes the presumed histologic diagnosis
of the lesion. Using a secret code, he stages the lesion as
an intraepithelial carcinoma, as a microinvasive carcinoma
not invading beyond the muscularis mucosae, or as a sub-
mucosal carcinoma.
The presumed diagnosis is passed on to the pathologist
using the secret code number. The resected specimen is an-
alyzed by serial histologic sections, and the degree of can-
cer invasion is measured by micrometry. The histologic
diagnosis then is confronted to the endoscopic diagnosis by
athirdpersonwhoestablishesacorrelationbetweenthe two.
RESULTS
Knowledge of the different morphologic aspects of early
esophageal carcinomas plays akey role in determining the
exact staging.
Among the macroscopic criteria that were studied, the
color of the lesion, the superficial spread, and the parietal
rigidity proved tobemostuseful in estimating the in-depth
tumoral invasion during endoscopy.
The different fundamental lesions (occult form, erythro-
plakia, leucoplakia, and leucoerythroplakia) are notrelated
to the same risk of tumor invasion (Table 3). The occult
form is never invasive. In our series, this was confirmed in
all 9 cases of early esophageal carcinomas. In another 18
cases, the same observation was made in the oral cavity
andpharynx. These data are in full agreementwith Chinese
results on larger series of early esophageal cancers.
Pure erythroplakia is either intraepithelial or microin-
vasive (46 of 49 cases). Exceptionally, the in-depth inva-
sion reaches the submucosa when the superficial
extension is larger than 2 cm2 or when slight rigidity of
the wall, associated with some surface irregularity, is pre-
sent. The leucoerythroplakia almost always corresponds
to an invasive lesion, and a submucosal extension must be
suspected in almost 40% of cases. The slightest rigidity
of the wall and a superficial extension ofmore than 2 cm
are further important signs related to submucosal exten-
sion. In the esophagus, the leucoerythroplakia thus corre-
sponds to the most advanced type of early cancer,
according to our criteria.
Leucoplakia may correspond to an intraepithelial, in-
tramucosal, or submucosal lesion. The degree of superfi-
cial extension is usually small. The presence of localized
rigidity of the wall is the only sign that helps determine
the submucosal infiltration when it is present.
A particular plakelike form of early esophageal cancer
can be extremely difficult to diagnose, because it does not
show any surface discoloration. Only a slight plakelike
rigidity of the wall, without any surface alteration, is vis-
ible. This form of early esophageal cancer derives from
dysplasia of the basal layers of the squamous cell epithe-
lium, with early invasion of the lamina propria but with-
out any dysplastic modification of the superficial layers
of the epithelium. This gives rise to an aggressive and in-
vasive squamous cell cancer of the esophagus.
Overall, the erythroplakias and occult forms represent
58% of all early esophageal cancers (Table 3). This indi-
cates that the less visible lesions occur most frequently.
This probably explains the poor diagnostic yield of rou-
tine upper GI endoscopies in detecting early esophageal
cancers, at least in Western countries (Froelicher and
Miller, 1985).
Superficial Extension
When a lesion shows a superficial extension less than
cm2, a microinvasion is likely in only 20% of the cases.
This figure rises to almost 90% if the lesion is larger than
2 cm2, whatever the fundamental lesion may be.ENDOSCOPIC FINDINGS OF 100 EARLY STAGE ESOPHAGEAL CANCERS 89
Table 3 Morphology versus in-depth invasion in 100 early esophageal carcinomas
LEUCO-ERYTHRO
PLAKIA
ERYTHROPLAKIA
LEUCOPLAKIA OCCULT FORM
2 16 11 3 7 3 14 32 3 9
is
sm
13 cases
..:..
29 cases 49 cases 9 cases
Note.raThe erythroplakias and occult forms represent 58% of all early esophageal cancers. Endoscopically, they are the most difficult to diagnose be-
cause of their almost normal appearance with respect to the surrounding normal mucosa. They represent, however, the most relevant lesions to diag-
nose, because 55 of58 correspond either to in situ or to intramucosal carcinomas, the prognosis ofwhich is excellent. The leucoerythroplakiacorresponds
to the most advanced form of early carcinomas, because almost half of the cases already invade the submucosa. The pure leucoplakia, easily detected
at endoscopy, is rare (13% of cases) and many correspond to in situ as well as to submucosal cancer.
Rigidity of the Wall
This sign of invasion has been observed in 16 of 17 sub-
mucosal carcinomas in this series. The only case that was
underestimated corresponded to an erythroplakia with a
superficial extension of more than 2 cm2. It was initially
staged as an intramucosal carcinoma, because no real
rigidity of the wall could be determined at endoscopy.
Combining these three criteria, we were able to predict
accurately or overevaluate the degree of in-depth invasion
in 55 (86%) of 64 early cancers of the aerodigestive tract
that were studied prospectively as described in Material
and Methods. In 9 (14%) cases, the lesion was undereval-
uated at endoscopy, but on each occasion the underestima-
tion was minimal. Only 3 lesions, which were considered
microinvasive at endoscopy and which eventually corre-
sponded to an invasion of more than 1 mm (twice 2 mm
and once 3 mm) could be assumed to have real negative
therapeutic consequences, because the submucosal exten-
sion bears a higher risk oflymph node metastasis than does
an intramucosal invasion. It is interesting that the 3 under-
evaluated lesions corresponded to a leucoerythroplakia in
2 cases and to an erythroplakia in 1 case, which confirms
their high tendency toward cancerous infiltration.
DISCUSSION
Definition of Early Squamous Cell Carcinoma of the
Esophagus
At present, the definition of early esophageal carcinoma is
based on the empirical notion of surgical curability.
Anatomically, itconcerns carcinomas limited to themucosa
andsubmucosawithoutlymphnode metastasis(pTaN0and
pTbN0). It is debatable, however, if submucosal carcino-
mas still shouldbe considered as early cancers. First, around
70% of the cases initially present with lymph node metas-
tasis at surgery, and second,TbN0cancersmaydevelop late
lymph node metastasis, as we ourselves have documented
in 11 consecutive cases followed up for more than 5 years.
Noneofthese 11 casesshowedevidenceofsecondpdmaxies
in the lungs, esophagus, or upper aerodigestive tract at au-
topsy. Thismeans thatsubmucosalcarcinomasoftheesoph-90 P. MONNIER et al.
agus, even without lymph node metastasis at the time of
surgery, are far from having 100% cure rates. We therefore
proposethatthedefinitionofearlyesophagealcancershould
be restricted to in situ and intmmucosal carcinomas with-
out lymph node metastasis (pTaN0).
Pretherapy Staging ofEarly Esophageal Cancer
This includes the precise evaluation of the in-depth inva-
sion of the primary tumor and the detection ofmediastinal
lymph node metastasis. Furthermore, at least in Europe
where the incidence of esophageal carcinoma is related to
tobacco and alcohol consumption, a routine pretherapy
bronchoesophagoscopy should be performed in all cases to
detect synchronous early asymptomatic cancers of the oral
cavity, pharynx, or tracheobronchial tree. This is especially
worthwhile in former head and neck cancer patients.
As we have demonstrated above, the endoscopic stag-
ing of esophageal cancers is based on the morphology,
surface extension, and slight parietal rigidity ofthe lesion.
This allows one to predict correctly the degree ofin-depth
invasion in approximately 95% of cases. Only 3 of 64 le-
sions were underevaluated in our series and could thus
have been responsible for a negative therapeutic conse-
quence. This means that a well-trained endoscopist can
differentiate an intramucosal from a submucosal carci-
noma with a fairly high degree of accuracy.
As far as the detection ofmediastinallymphnode metas-
tasis is concerned, onlyendoscopic ultrasonography (EUS)
really is useful. Of 113 squamous cell carcinomas, Tio et
al., (1989) demonstrated a positive correlation between
EUS and histology in 100% ofT and T2 esophageal can-
cers, whereas the rate was lower for T3 and T4 cancers. In
the latter, the tumoral stenosis often prevents the progres-
sion of the EUS device beyond the tumor to examine the
lymph nodes.
Overall, the accuracyofthepretreatment staging (tumor
andlymph nodes) is approximately 82% with theEUS for
T and T2 cancers. This figure drops to only 12% with CT.
In view of these data, it seems that our endoscopic stag-
ing system, combined with the endoscopic ultrasonogra-
phy forthe detectionoflymphnode metastases, represents
the best pretherapy investigation to predict the future suc-
cess of a pure endoscopic treatment of early esophageal
carcinomas. EUS may further reinforce or invalidate the
endoscopic staging of the primary tumor based on endo-
scopic criteria.
Treatment ofEarly Esophageal Cancer
In 1980, the early report of Earlam and Cunha-Melo
(1980) on the surgical treatment ofesophageal carcinoma
mentioned a resectability rate of only 22% and a poor 5-
year survival rate of only 3%.
Because of the greater availability of endoscopy, al-
lowing diagnosis at an earlier stage, and of the expertise
of some surgical centers, the prognosis and outcome of
this dismal disease have steadily improved over the last
decade. More radical resection procedures with posterior
mediastinectomy (Akiyama et al., 1981; Lerut et al.,
1992), en bloc resection (Altorki and Skinner, 1990), and
three field dissections (Tsurumaru et al., 1990) have been
developedto increase thechanceforlocalcontrolandcure.
If 5-year survival rates remain around 90% in stage I
cancers (Lerut et al., 1992), they are deceptively low for
stage III and to a lesser extent for stage II lesions, at least
in Western countries where tobacco and alcohol con-
sumption plays a major role as risk factors. The debili-
tated patients, often presenting with multiple internal
pathologies, represent poor surgical candidates.
Although some specialized centers in thoracic surgery
report a resectability rate of 77% (Lerut et al., 1992) for
all esophageal cancers, one must admit that the largest
group ofpatients are detected at a late stage of the disease
(stages III and IV). The only hope for cure, therefore, lies
in the earlier detection ofesophageal carcinomas. As long
as mediastinal lymph nodes are free of metastasis at
surgery, superficial cancers have a good prognosis.
Several groups from Japan (Endo et al., 1986; Japanese
Research Society for Esophageal Disease, 1989), China
(Chinese Academy of Medical Science and Honan
Province, 1973) and Western countries (Lerut et al., 1992;
Altorkiand Skinner, 1990; Gignoux and Segal, 1984)have
shown that the 5-year survival rates ofpTN0 carcinomas
have increased from 60% to almost 90%, depending on
the proportion ofTaandTlb carcinomas included in their
series.
The safest treatment modality for early esophageal car-
cinoma is surgical resection with mediastinal lymph node
dissection. There are, however, poor surgical candidates
presenting with multiple associated pathologies, multiple
synchronous or metachronous head and neck cancers, ad-
vanced age, and poor general condition caused by alco-
hol consumption, and other factors. Aggressive surgical
treatment often is associated with a high morbidity and
mortality in these patients.
For obvious ethical reasons, an endoscopic treatment of
early esophageal carcinoma can be foreseen only after a
thorough collegial discussion including surgeons, radio-
therapists, chemotherapists, and the patient. It is clear that
a final decision can be taken only according to each case,
given the complexity of the parameters affecting each pa-
tient (age, general stage, associated illness, previous on-
cological treatments and synchronous multiple cancers).ENDOSCOPIC FINDINGS OF 100 EARLY STAGE ESOPHAGEAL CANCERS 91
At present, the endoscopic cure ofearly cancers can be
approached in three different ways:
1. Endoscopic mucosectomy. This technique, described
by Inoue and Endo (1990), is applicable to small le-
sions only, with a limited superficial spread. It has the
great advantage of providing a surgical specimen for
a histologic examination. Technically, it is not always
easy to perform and cannot be used for large superfi-
cial extensions.
2. Vaporization with a thermal laser. This technique is
only applicable to small lesions, the superficial ex-
tension of which is about 1 cm2. A carbon dioxide
laser is preferable to a Nd:YAG laser for better con-
trol the in-depth vaporization without risk of induc-
ing a secondary perforation of the organ wall.
3. Photodynamic therapy. In the esophagus, this treat-
ment modality allows one to cure widespread su-
perficia lesions (several cm2) provided they remain
intramucosal (TaN0) and that they are not circum-
ferential. A circular mucosal necrosis would induce
a stenosis during the healing process. Our experi-
ence with PDT of 35 early esophageal carcinomas
(Monnier et al., 1992) has shown that the results are
quite favorable for in situ and intramucosal carci-
nomas, with a recurrence rate of less than 8% (2/27
lesions). For submucosal carcinomas, the local re-
currence rate is much higher (--25%), and the risk of
lymph node metastases must notbe underestimated.
In a good surgical candidate, a TbN0 carcinoma must be
treated surgically, with a complete esophageal resection
and an extensive mediastinal lymph node dissection.
CONCLUSIONS
Given our present knowledge, early esophageal carcino-
mas can be characterised as follows:
1. The definitionofearlyesophageal carcinomashould
be restricted to pTaN0 cancers.
2. The endoscopic aspect of in situ and microinvasive
carcinomas is variable, and their early diagnosis by
endoscopy is difficult. They are classified into four
morphologic types.
3. The most common endoscopic aspect is the ery-
throplakia, fiat or slightly depressed, often multi-
centric (80% of cases).
4. Toluidine blue or the Lugol iodine solution are of
considerable help in determining the precise topog-
raphy and extent of early cancers, which are poorly
visible or invisible (erythroplakia and occult forms).
5. Based on morphologic criteria, superficial spread,
and localized rigidity of the wall, it is possible to es-
timate the endoscopic staging ofan early carcinoma
with a fairly high degree ofaccuracy (approximately
95%).
6. EUS is invaluable in the staging of lymph node
metastases and may help confirm or invalidate the
stage of in-depth tumoral invasion.
7. In poor surgical candidates, photodynamic therapy
or endoscopic mucosectomy represents the best
treatment options for TlaN0 carcinomas.
8. ForTbN0 carcinomas, an esophageal resection with
extensive mediastinal lymph node dissection must
be undertaken in good surgical candidates. In inop-
erable patients, PDT combined with radiotherapy
represents an alternative treatment.
9. For epidemiologic reasons (alcohol and tobacco con-
sumption in Western countries), the pretherapy
workup ofearly esophageal cancers should include a
bronchoesophagoscopy with a complete otolaryngo-
logic examination to detect early synchronous can-
cers of the mouth, pharynx, or tracheobronchial tree.
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